Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELLEN A NEYLON

Physician Assistants & Advanced Practice Nursing Providers Clinical Nurse Specialist Oncology

NPI
1174894554
CMS profile
11137607
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$17,163.14

98 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELLEN A NEYLON

NPI 1174894554 · CMS profile ID 11137607

Physician Assistants & Advanced Practice Nursing Providers / Clinical Nurse Specialist / Oncology

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174894554?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174894554?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174894554?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ELLEN A NEYLON, NPI 1174894554, CMS profile ID 11137607, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–98 of 98 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1174894554?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

98 matching records · $17,163.14 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 98 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–98 of 98.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $124.8807/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829636319 CMS
AbbVie Inc. $19.1807/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795039919 CMS
Lilly USA, LLC $12.4407/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860806621 CMS
DEXCOM, INC. $114.2807/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845321103 CMS
Novo Nordisk Inc $2.4007/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810732675 CMS
Novo Nordisk Inc $13.8707/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810732679 CMS
AbbVie Inc. $13.6307/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795039915 CMS
Chiasma, Inc. $64.9907/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815998759 CMS
Novo Nordisk Inc $15.9606/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810732669 CMS
Novo Nordisk Inc $125.0006/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811164187 CMS
Novo Nordisk Inc $1,235.0006/29/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811511505 CMS
Novo Nordisk Inc $69.0806/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810848251 CMS
Nestle HealthCare Nutrition Inc. $129.5406/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821014919 CMS
Lilly USA, LLC $13.3006/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818872973 CMS
Abbott Laboratories $24.1506/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815562249 CMS
Novo Nordisk Inc $10.1006/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810848247 CMS
Lilly USA, LLC $13.2006/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860806893 CMS
AstraZeneca Pharmaceuticals LP $11.4906/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829713365 CMS
AstraZeneca Pharmaceuticals LP $16.4706/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829429643 CMS
Lilly USA, LLC $12.9505/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860807177 CMS
SANOFI-AVENTIS U.S. LLC $16.0905/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843677157 CMS
Antares Pharma, Inc. $11.8905/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827511253 CMS
Lilly USA, LLC $4.5505/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860807627 CMS
Novo Nordisk Inc $123.8505/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810848241 CMS
Novo Nordisk Inc $14.4705/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811282479 CMS
Xeris Pharmaceuticals, Inc. $11.8904/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837464499 CMS
SANOFI-AVENTIS U.S. LLC $20.6304/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843677139 CMS
Lilly USA, LLC $14.1004/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 860808913 CMS
Novo Nordisk Inc $15.3804/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811282473 CMS
Chiasma, Inc. $116.9203/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815998755 CMS
Abbott Laboratories $2.8203/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818448187 CMS
Abbott Laboratories $19.4103/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818448189 CMS
Amgen Inc. $23.6603/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826001269 CMS
Novo Nordisk Inc $14.5703/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811511499 CMS
AstraZeneca Pharmaceuticals LP $23.3203/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830069401 CMS
Horizon Therapeutics plc $126.4203/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797247619 CMS
Novo Nordisk Inc $13.0302/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811397329 CMS
SANOFI-AVENTIS U.S. LLC $18.5802/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843677115 CMS
DEXCOM, INC. $12.6502/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845321101 CMS
Novo Nordisk Inc $1,130.5002/15/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811282467 CMS
Novo Nordisk Inc $15.6902/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810732665 CMS
AstraZeneca Pharmaceuticals LP $16.6002/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829406937 CMS
Amneal Pharmaceuticals LLC $13.6801/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829695777 CMS
Novo Nordisk Inc $19.1301/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811625243 CMS
SANOFI-AVENTIS U.S. LLC $11.7101/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843677159 CMS
Novo Nordisk Inc $15.0001/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811282463 CMS
DEXCOM, INC. $11.4901/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845321099 CMS
Corcept Therapeutics $15.5301/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837520219 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $17,163.14 98
PY2022 $20,622.47 122
PY2023 $47,947.98 239
PY2024 $32,086.49 185
PY2025 $20,593.02 143

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Recipient $1,439.69 19
PY2023 Recipient $1,837.01 11
PY2022 Recipient $2,645.48 10

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

19 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient ABBVIE INC. $156.53 04/13/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100683001
Recipient ABBVIE INC. $50.54 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682989
Recipient ABBVIE INC. $37.50 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682991
Recipient ABBVIE INC. $69.00 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682993
Recipient ABBVIE INC. $12.73 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682995
Recipient ABBVIE INC. $7.17 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682997
Recipient ABBVIE INC. $32.70 04/12/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682999
Recipient ABBVIE INC. $226.86 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682977
Recipient ABBVIE INC. $37.50 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682979
Recipient ABBVIE INC. $70.25 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682981
Recipient ABBVIE INC. $50.54 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682983
Recipient ABBVIE INC. $25.00 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682985
Recipient ABBVIE INC. $125.05 04/11/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682987
Recipient ABBVIE INC. $176.86 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682965
Recipient ABBVIE INC. $37.10 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682967
Recipient ABBVIE INC. $259.98 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682969
Recipient ABBVIE INC. $21.80 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682971
Recipient ABBVIE INC. $17.64 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682973
Recipient ABBVIE INC. $24.94 04/10/2024 Covered Recipient Non-Physician Practitioner A Phase 2/3 Multicenter, Double Blinded, Randomized, Dose-conversion, Active Control Study Examining the Efficacy and Safety of Armour Thyroid Compared to Synthetic T4 for the Treatment of Adults With Primary Hypothyroidism No dispute reported 06/30/2026 1100682975